Skip to content

Comunicados à imprensa

Stratus Medical raises $10 million Series B to complete development of new technology and fund clinical trial

Por

MAGNOLIA, Texas, Feb. 4, 2026 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced a $10 million Series B financing. The financing was led by Wasatch Health Partners, a healthcare-focused investment firm pursuing growth equity and lower middle-market buyout strategies. Wasatch Health Partners invested through its Growth Fund and previously provided a $25 million convertible debt facility through its Structured Capital platform.

Stratus® Medical anuncia acordo de distribuição exclusiva com o AMS Group SRL para a Itália

Por

Stratus Medical announces exclusive distribution agreement with AMS GROUP SRL to bring the NIMBUS® RF Multitined Expandable Electrode to Italy! 🇮🇹 AMS GROUP SRL is a leading medical device distributor focused on interventional pain therapies. AMS will launch NIMBUS in Italy with an upcoming educational education program. Will Pankey, VP of Sales for Stratus, is … Ler mais

Stratus® Medical anuncia acordo de distribuição exclusiva com a Edge Medical para o Reino Unido

Por

Stratus® Medical Announces Exclusive Distribution Agreement with Edge Medical for the United Kingdom MAGNOLIA, Texas, Aug. 22, 2024 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for pain, is pleased to announce an exclusive distribution agreement with Edge Medical, a leading medical device distributor serving the United Kingdom. Edge Medical will distribute the innovative … Ler mais

A Stratus® Medical anuncia a expansão contínua de sua cobertura de propriedade intelectual na Europa com acréscimos ao seu portfólio global de patentes para o Eletrodo Expansível Multitinado RF Eletrocirúrgico NIMBUS® e o registro de um projeto comunitário para a nova tecnologia de plataforma em desenvolvimento

Por

MAGNOLIA, Texas, April 29, 2024 /PRNewswire/ — Stratus® Medical, a company focused on improving clinical outcomes for chronic pain patients by advancing radiofrequency (RF) technology for the treatment of pain, announced today the expansion of patent protection in Europe for its NIMBUS® Electrosurgical RF Multitined Expandable Electrode (“NIMBUS”) with the issuance of European Patent Numbers EP3556308 and EP3750501. Both … Ler mais

Nova evidência retrospectiva para RFA com NIMBUS, para dor na SIJ, comparando duas técnicas em 182 pacientes em 12 meses

Por

Nova evidência retrospectiva para ablação por radiofrequência com Nimbus, para dor na SIJ, comparando duas técnicas em 182 pacientes em 12 meses. Parabéns aos autores pela publicação desse manuscrito, que está disponível on-line em acesso aberto: https://esmed.org/MRA/mra/article/view/4978 Citation: Wright RE and Block JE, 2023. Radiofrequency Neurotomy for Sacroiliac Joint Pain: Twelve Month Outcomes and Comparison Between Two … Ler mais

Stratus® Medical anuncia o primeiro paciente inscrito em um importante estudo comparativo, duplo-cego, randomizado, comparando o dispositivo de ablação por radiofrequência Nimbus® com a ablação por radiofrequência convencional para o tratamento da dor na articulação sacroilíaca

Por

MAGNOLIA, Texas, March 2, 2023 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for pain, and the University of Utah, Department of Physical Medicine and Rehabilitation, announced today the first patient enrolled in the COBRA study, a double-blinded, randomized trial, comparing the bipolar treatment with Nimbus® RF Multitined Expandable Electrode to conventional radiofrequency … Ler mais

Stratus® Medical anuncia a emissão da terceira patente nos Estados Unidos para o Eletrodo Expansível Multitinado Nimbus® RF usado no tratamento da dor

Por

MAGNOLIA, Texas, Feb. 23, 2021 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency ablation (RFA) treatment for chronic pain, announced today that the United States Patent and Trademark Office has granted a third U.S. patent related to its Nimbus® RF Multitined Expandable Electrode. U.S. Patent No. 10,925,664, titled METHODS FOR RADIO FREQUENCY NEUROTOMY, issued on February … Ler mais

A Stratus® Medical anuncia duas novas patentes nos Estados Unidos emitidas para o Eletrodo Expansível Multitinado Nimbus® RF utilizado no tratamento da dor

Por

SALT LAKE CITY, Sept. 14, 2020 /PRNewswire/ — Stratus®  Medical, a company focused on advancing radiofrequency ablation (RFA) treatment for chronic pain, announced today that the United States Patent and Trademark Office has granted two new patents related to its Nimbus® RF Multitined Expandable Electrode. U.S. Patent No. 10,716,618, titled System and Methods for Tissue Ablation, issued … Ler mais

Stratus® Medical anuncia a liberação da FDA 510k para a Cânula RF Vesta® para expandir o portfólio de produtos e os primeiros tratamentos de pacientes Vesta nos Estados Unidos

Por

SALT LAKE CITY, July 27, 2020 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced today FDA clearance for the Vesta RF Cannula for use in radiofrequency (RF) heat lesion procedures for the relief of pain and first Vesta patient treatments in the United States.   Vesta was developed to provide our … Ler mais